Business Segments Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Pharmaceuticals

Real-time Estimate Cboe BZX 11:30:00 2025-01-14 am EST 5-day change 1st Jan Change
55.66 USD +0.53% Intraday chart for Bristol-Myers Squibb Company -2.71% -1.71%

Sales 2023 by Business Segment

See more © MarketScreener.com

Sales 2023 by Geography

See more © MarketScreener.com

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (USD)
Fiscal Period: December2014201520162017201820192020202120222023

Pharmaceutical Products

          

Pharmaceuticals

26.14B 42.52B 46.38B 46.16B 45.01B

Total Assets

130B 118B 109B 96.82B 95.16B

Interest Expense

-656M -1.38B -1.29B -1.15B -1.16B

Income Tax Expense

1.52B 2.12B 1.08B 1.37B 400M

CAPEX

-836M -753M -973M -1.12B -1.21B

EBT

4.98B -6.87B 8.1B 7.71B 8.44B

D&A

1.68B 10.43B 10.76B 10.28B 9.77B

Net Income

3.44B -9.02B 6.99B 6.33B 8.02B

Geographical Revenue Distribution History

Geographical breakdown of sales (USD)
Fiscal Period: December2014201520162017201820192020202120222023

United States

15.34B 26.58B 29.21B 31.83B 31.56B

Total Assets

4.84B 4.5B 4.71B 4.83B 5.04B

International

- - - 13.5B 12.75B

Total Assets

- - - 1.42B 1.61B

Unallocated

524M 631M 852M 834M 699M

Japan

- - - - -

Europe

6.27B 9.85B 10.69B - -

Total Assets

1.29B 1.24B 1.18B - -

Rest of The World

4.01B 5.46B 5.63B - -

Total Assets

126M 142M 163M - -